Urotensin II promotes the proliferation of endothelial progenitor cells through p38 and p44/42 MAPK activation

Molecular Medicine Reports

Volumn 6, Issue 1, 2012, Pages 197-200

  Xu, Shengkai ^a   Wen, Huazhi ^a   Jiang, Hong ^b  

^a GANSU PROVINCIAL HOSPITAL   (China)

^b RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

Endothelial progenitor cells; Mitogen activated protein kinase; Proliferation; Rat; Urotensin II

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; G PROTEIN COUPLED RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; URANTIDE; UROTENSIN II;

ANIMAL CELL; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; BONE MARROW; CARDIOVASCULAR SYSTEM; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; CULTURE MEDIUM; ENDOTHELIAL PROGENITOR CELL; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; MALE; NONHUMAN; PEPTIDE SYNTHESIS; RAT; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANIMALS; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; ENZYME ACTIVATION; MALE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; STEM CELLS; UROTENSINS;

BOVINAE; RATTUS;

EID: 84861643919     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2012.899     Document Type: Article

References (17)

1. Ames RS, Sarau HM, Chambers JK, Willette RN, Aiyar NV, Romanic AM, Louden CS, Foley JJ, Sauermelch CF, Coatney RW, et al: Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14. Nature 401: 282-286, 1999.
2. Maguire JJ and Davenport AP: Is urotensin-II the new endothelin? Br J Pharmacol 137: 579-588, 2002. (Pubitemid 35333083)
3. Matsushita M, Shichiri M, Imai T, Iwashina M, Tanaka H, Takasu N and Hirata Y: Co-expression of urotensin II and its receptor (GPR14) in human cardiovascular and renal tissues. J Hypertens 19: 2185-2190, 2001. (Pubitemid 33135240)
4. Xu S, Jiang H, Wu B, Yang J and Chen S: Urotensin II induces migration of endothelial progenitor cells via activation of the RhoA/Rho kinase pathway. Tohoku J Exp Med 219: 283-288, 2009.
5. Zentilin L, Tafuro S, Zacchigna S, Arsic N, Pattarini L, Sinigaglia M and Giacca M: Bone marrow mononuclear cells are recruited to the sites of VEGF-induced neovascularization but are not incorporated into the newly formed vessels. Blood 107: 3546-3554, 2006.
6. Jamur MC, Grodzki AC, Moreno AN, de Mello Lde F, Pastor MV, Berenstein EH, Siraganian RP and Oliver C: Identification and isolation of rat bone marrow-derived mast cells using the mast cell-specific monoclonal antibody AA4. J Histochem Cytochem 49: 219-228, 2001. (Pubitemid 32113384)
7. Liu Q, Pong SS, Zeng Z, Zhang Q, Howard AD, Williams DL Jr, Davidoff M, Wang R, Austin CP, McDonald TP, et al: Identification of urotensin II as the endogenous ligand for the orphan G-protein-coupled receptor GPR14. Biochem Biophys Res Commun 266: 174-178, 1999. (Pubitemid 30028787)
8. Mori M, Sugo T, Abe M, Shimomura Y, Kurihara M, Kitada C, Kikuchi K, Shintani Y, Kurokawa T, Onda H, et al: Urotensin II is the endogenous ligand of a G-protein-coupled orphan receptor, SENR (GPR14). Biochem Biophys Res Commun 265: 123-129, 1999.
9. Shi L, Ding W, Li D, Wang Z, Jiang H, Zhang J and Tang C: Proliferation and anti-apoptotic effects of human urotensin II on human endothelial cells. Atherosclerosis 188: 260-264, 2006. (Pubitemid 44313921)
10. Watanabe T, Pakala R, Katagiri T and Benedict CR: Synergistic effect of urotensin II with serotonin on vascular smooth muscle cell proliferation. J Hypertens 19: 2191-2196, 2001. (Pubitemid 33135241)
11. Douglas SA, Tayara L, Ohlstein EH, Halawa N and Giaid A: Congestive heart failure and expression of myocardial urotensin II. Lancet 359: 1990-1997, 2002. (Pubitemid 34663713)
12. Everaert BR, Van Craenenbroeck EM, Hoymans VY, Haine SE, Van Nassauw L, Conraads VM, Timmermans JP and Vrints CJ: Current perspective of pathophysiological and interventional effects on endothelial progenitor cell biology: focus on PI3K/AKT/eNOS pathway. Int J Cardiol 144: 350-366, 2010.
13. Giannotti G, Doerries C, Mocharla PS, Mueller MF, Bahlmann FH, Horvath T, Jiang H, Sorrentino SA, Steenken N, Manes C, et al: Impaired endothelial repair capacity of early endothelial progenitor cells in prehypertension: relation to endothelial dysfunction. Hypertension 55: 1389-1397, 2010.
14. Stefano RD, Barsotti MC, Felice F, Vlachopoulos C and Balbarini A: Endothelial progenitor cells in prehypertension. Curr Pharm Des 17: 3002-3019, 2011.
15. Wang H, Mehta JL, Chen K, Zhang X and Li D: Human urotensin II modulates collagen synthesis and the expression of MMP-1 in human endothelial cells. J Cardiovasc Pharmacol 44: 577-581, 2004. (Pubitemid 39441698)
16. Djordjevic T, BelAiba RS, Bonello S, Pfeilschifter J, Hess J and Gorlach A: Human urotensin II is a novel activator of NADPH oxidase in human pulmonary artery smooth muscle cells. Arterioscler Thromb Vasc Biol 25: 519-525, 2005. (Pubitemid 40315672)
17. Tamura K, Okazaki M, Tamura M, Isozumi K, Tasaki H and Nakashima Y: Urotensin II-induced activation of extracellular signal-regulated kinase in cultured vascular smooth muscle cells: involvement of cell adhesion-mediated integrin signaling. Life Sci 72: 1049-1060, 2003. (Pubitemid 35454129)